Literature DB >> 23539193

Lipocalin-2 is associated with a good prognosis and reversing epithelial-to-mesenchymal transition in pancreatic cancer.

Bin Xu1, Da-Yong Jin, Wen-Hui Lou, Dan-Song Wang.   

Abstract

BACKGROUND: Lipocalin-2 is a multifaceted modulator in cancer progression. Its clinical significance is not clear in pancreatic cancer. The purpose of this study was to investigate whether lipocalin-2 is associated with good prognosis by reversing epithelial-to-mesenchymal transition (EMT) in pancreatic cancer.
METHODS: Lipocalin-2, E-cadherin, or vimentin expression was detected in 60 pancreatic adenocarcinoma specimens. Correlations between lipocalin-2 expression and EMT, the clinicopathologic characteristics, and prognosis were investigated. Whether pancreatic cancer cells' migration and invasion (some characteristics of EMT) were affected by lipocalin-2 was also explored.
RESULTS: High lipocalin-2 expression was significantly associated with a good prognosis in pancreatic cancer (p < 0.05). Overexpression of lipocalin-2 correlated with a lower extent of EMT (p < 0.05), increased E-cadherin expression (p < 0.05), decreased vimentin expression (p < 0.05), and reduced cancer cell migration and invasion in pancreatic cancer.
CONCLUSIONS: Lipocalin-2 may be considered an epithelial inducer, which may reverse EMT and predict a good prognosis in pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23539193     DOI: 10.1007/s00268-013-2009-6

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  40 in total

Review 1.  Pancreatic cancer.

Authors:  Manuel Hidalgo
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

2.  Lipocalin 2 antagonizes the proangiogenic action of ras in transformed cells.

Authors:  Shivalingappa Venkatesha; Jun-Ichi Hanai; Pankaj Seth; S Ananth Karumanchi; Vikas P Sukhatme
Journal:  Mol Cancer Res       Date:  2006-11       Impact factor: 5.852

Review 3.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

4.  Up-regulation of neutrophil gelatinase-associated lipocalin in oral squamous cell carcinoma: relation to cell differentiation.

Authors:  Takashi Hiromoto; Kazuma Noguchi; Michiyo Yamamura; Yusuke Zushi; Emi Segawa; Kazuki Takaoka; Kuniyasu Moridera; Hiromitsu Kishimoto; Masahiro Urade
Journal:  Oncol Rep       Date:  2011-08-24       Impact factor: 3.906

5.  Cdk1-phosphorylated CUEDC2 promotes spindle checkpoint inactivation and chromosomal instability.

Authors:  Yan-Fei Gao; Teng Li; Yan Chang; Yu-Bo Wang; Wei-Na Zhang; Wei-Hua Li; Kun He; Rui Mu; Cheng Zhen; Jiang-Hong Man; Xin Pan; Tao Li; Liang Chen; Ming Yu; Bing Liang; Yuan Chen; Qing Xia; Tao Zhou; Wei-Li Gong; Ai-Ling Li; Hui-Yan Li; Xue-Min Zhang
Journal:  Nat Cell Biol       Date:  2011-07-10       Impact factor: 28.824

6.  Cancer statistics, 2010.

Authors:  Ahmedin Jemal; Rebecca Siegel; Jiaquan Xu; Elizabeth Ward
Journal:  CA Cancer J Clin       Date:  2010-07-07       Impact factor: 508.702

Review 7.  Options for the treatment of gemcitabine-resistant advanced pancreatic cancer.

Authors:  Ioannis Gounaris; Kamarul Zaki; Pippa Corrie
Journal:  JOP       Date:  2010-03-05

8.  Lipocalin 2: a multifaceted modulator of human cancer.

Authors:  Jiang Yang; Marsha A Moses
Journal:  Cell Cycle       Date:  2009-08-08       Impact factor: 4.534

Review 9.  Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: a new protein enters the scene.

Authors:  Davide Bolignano; Valentina Donato; Antonio Lacquaniti; Maria Rosaria Fazio; Caterina Bono; Giuseppe Coppolino; Michele Buemi
Journal:  Cancer Lett       Date:  2009-06-18       Impact factor: 8.679

10.  E-cadherin expression in primary carcinomas of the breast and its distant metastases.

Authors:  Paul J Kowalski; Mark A Rubin; Celina G Kleer
Journal:  Breast Cancer Res       Date:  2003-09-26       Impact factor: 6.466

View more
  10 in total

Review 1.  Lipocalin-2 expression and function in pancreatic diseases.

Authors:  Kristyn Gumpper; Andrew William Dangel; Valentina Pita-Grisanti; Somashekar G Krishna; Luis F Lara; Thomas Mace; Georgios I Papachristou; Darwin L Conwell; Phil A Hart; Zobeida Cruz-Monserrate
Journal:  Pancreatology       Date:  2020-01-07       Impact factor: 3.996

2.  Hepatocyte-Derived Lipocalin 2 Is a Potential Serum Biomarker Reflecting Tumor Burden in Hepatoblastoma.

Authors:  Laura Molina; Danielle Bell; Junyan Tao; Morgan Preziosi; Tirthadipa Pradhan-Sundd; Sucha Singh; Minakshi Poddar; Jianhua Luo; Sarangarajan Ranganathan; Maria Chikina; Satdarshan P Monga
Journal:  Am J Pathol       Date:  2018-06-18       Impact factor: 4.307

Review 3.  Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality.

Authors:  Emily Jane Gallagher; Derek LeRoith
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

Review 4.  Implication and role of neutrophil gelatinase-associated lipocalin in cancer: lipocalin-2 as a potential novel emerging comprehensive therapeutic target for a variety of cancer types.

Authors:  Sina Rahimi; Amaneh Mohammadi Roushandeh; Ebrahim Ahmadzadeh; Ali Jahanian-Najafabadi; Mehryar Habibi Roudkenar
Journal:  Mol Biol Rep       Date:  2020-01-22       Impact factor: 2.316

5.  An early-screening biomarker of endometrial carcinoma: NGAL is associated with epithelio-mesenchymal transition.

Authors:  Ting Li; Li Yu; Jia Wen; Qinping Liao; Zhaohui Liu
Journal:  Oncotarget       Date:  2016-12-27

Review 6.  Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous Disease.

Authors:  James H Monkman; Erik W Thompson; Shivashankar H Nagaraj
Journal:  Cancers (Basel)       Date:  2019-11-07       Impact factor: 6.639

7.  Prognostic and Clinicopathological Significance of E-Cadherin in Pancreatic Cancer Patients: A Meta-Analysis.

Authors:  Pengbo Wang; Zengkuan Zhu
Journal:  Front Oncol       Date:  2021-04-12       Impact factor: 6.244

Review 8.  Role of neutrophil gelatinase-associated lipocalin in renal cell carcinoma.

Authors:  Kai Che; Wenkai Han; Mingxin Zhang; Haitao Niu
Journal:  Oncol Lett       Date:  2020-12-24       Impact factor: 2.967

Review 9.  Obesity and Pancreatic Cancer: Insight into Mechanisms.

Authors:  Guido Eibl; Enrique Rozengurt
Journal:  Cancers (Basel)       Date:  2021-10-10       Impact factor: 6.639

Review 10.  The role of lipocalin-2 in age-related macular degeneration (AMD).

Authors:  Sayan Ghosh; Nadezda Stepicheva; Meysam Yazdankhah; Peng Shang; Alan M Watson; Stacey Hose; Haitao Liu; Joseph Weiss; J Samuel Zigler; Mallika Valapala; Simon C Watkins; Debasish Sinha
Journal:  Cell Mol Life Sci       Date:  2020-01-04       Impact factor: 9.261

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.